Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: Effect of ursodeoxycholic acid

Hepatology

Volumn 11, Issue 1, 1990, Pages 12-15

  Calmus, Yvon ^a   Gane, Pierre ^a   Rouger, Philippe ^a   Poupon, Raoul ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

URSODEOXYCHOLIC ACID;

ADULT; AGED; ARTICLE; BILIARY CIRRHOSIS; CLINICAL ARTICLE; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

DEOXYCHOLIC ACID; FLUORESCENT ANTIBODY TECHNIQUE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMAN; LIVER; LIVER CIRRHOSIS, BILIARY; MIDDLE AGE; URSODEOXYCHOLIC ACID;

EID: 0025098908     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.1840110104     Document Type: Article

References (15)

1. HLA‐A, B, C, HLA‐D/DR and HLA‐D/DQ expression on unfixed liver biopsy sections from patients with chronic liver disease
2. Immunohistochemical analysis of HLA (A, B, C) antigens in liver disease using a monoclonal antibody
3. Expression of blood group antigens including HLA markers in human adult liver
4. Aberrant expression of HLA‐DR antigens on bile duct epithelium in primary biliary cirrhosis: relevance to pathogenesis
5. Hepatic ß2‐microglobulin distribution in primary biliary cirrhosis
6. The role of gene products of the major histocompatibility complex in T cell activation and cellular interactions.
7. Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?
8. Ursodeoxycholic acid for primary biliary cirrhosis.
9. Structural and genetic analyses of HLA class I molecules using monoclonal xenoantibodies
10. k cross‐reacting with human DR molecules. I. Cross‐inhibition studies of mAb cell surface fixation and differential binding of mAb to detergent‐solubilized HLA molecules immobilized to a solid phase by a first mAb
11. Specificity of monoclonal antibodies directed against human and murine class II histocompatibility antigens as analyzed by binding to HLA‐deletion mutant cell lines
12. Role of abcrrant HLA‐DR expression and antigen presentation in induction of endocrine autoimmunity
13. A molecular basis for MHC class II‐associated autoimmunity
14. Increased expression of major histocompatibility antigens in the liver as a result of cholestasis
15. Ultrastructural immunocytochemical analysis of lymphocytes infiltrating bile duct epithelia in primary biliary cirrhosis